optimizing car-t outcomes in dlbcl: possible combination strategies & sequencing of agents
Published 1 year ago • 113 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
2:11
improving treatment outcomes of car t-cell therapy
-
3:21
safety management of car-t cell therapy in dlbcl
-
3:05
car-t therapy in r/r dlbcl
-
3:33
determining the optimal sequencing of bispecifics and car-t cells in patients with myeloma
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:55
developing the next generation of car-t cells
-
1:02
the use of car-t cell products in a real-world setting
-
16:43
engineering better car t cells: an interview with cri star yvonne chen, phd
-
1:06:58
optimization and functional characterization of car t and car nk cells
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
2:23
patient selection for autosct in hl & increasing cr rate before autosct with novel salvage regimens
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
3:56
considerations and challenges of integrating car-t and transplantation in b-all
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:48
innovative new approaches required for the practical implementation of car t-cell therapy
-
3:59
strategies to improve car t-cell manufacturing
-
4:17
preparing for the commercialization of car-t products
-
2:02
improving t-cell therapy with antigen specific t-cells
-
2:06
managing and treating crs, neurological toxicity and cytopenias associated with car-t therapy
-
1:02
the changing standard of care in dlbcl
-
3:18
out of specification car t-cells